0
Signin
countryflagCA

888-969-2592

RY 144.17 0.4529% TD 77.39 0.0517% SHOP 78.87 -1.3878% CNR 171.64 0.5625% ENB 50.09 -0.4769% CP 110.62 0.6277% BMO 128.85 -0.548% TRI 233.58 1.1563% CNQ 103.29 -0.174% BN 60.87 -0.2295% ATD 75.6 -1.447% CSU 3697.0 1.1582% BNS 65.76 -0.3485% CM 66.6 -0.5525% SU 54.21 1.1569% TRP 53.15 0.3398% NGT 58.54 -0.3405% WCN 226.5 0.4123% MFC 35.905 0.9986% BCE 46.75 -0.5954%

Titan Medical Inc

Healthcare CA TMD

0.055CAD
-0.005(8.33%)

Last update at 2024-05-16T19:07:00Z

Day Range

0.050.06
LowHigh

52 Week Range

0.081.30
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -42.59800M -14.80200M -24.18466M -41.90708M -22.63927M
Minority interest - - - - -
Net income -42.54200M -14.85800M -49.68766M -22.14441M -22.63927M
Selling general administrative 10.90M 12.43M 7.49M 7.53M 6.57M
Selling and marketing expenses - - 0.14M 0.29M 0.23M
Gross profit - 20.09M 20.00M - 0.00000M
Reconciled depreciation 0.86M 0.70M 0.24M 0.03M 0.03M
Ebit - -30.98700M 2.95M -61.24676M -22.63927M
Ebitda -41.59100M -29.61000M 2.65M -61.21421M -22.61023M
Depreciation and amortization - 1.38M -0.29916M 0.03M 0.03M
Non operating income net other - - - - -
Operating income -47.08700M -30.98700M 2.95M -61.24676M -39.69034M
Other operating expenses - 51.08M 15.80M 59.27M 39.69M
Interest expense 0.15M 0.12M 1.09M 0.42M 0.98M
Tax provision -0.05600M 0.06M - - -
Interest income 4.49M 15.58M 27.83M 19.92M 17.38M
Net interest income -0.00300M -0.05200M -2.87839M -2.40444M -1.02404M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.06M 25.50M -19.76267M 0.00000M
Total revenue 0.00000M 20.09M 20.00M 0.00000M 0.00000M
Total operating expenses 44.77M 51.08M 15.80M 59.27M 39.69M
Cost of revenue - - - - 0.00000M
Total other income expense net 2.18M 16.18M -27.13022M 19.34M 17.05M
Discontinued operations - - - - -
Net income from continuing ops -42.54200M -14.85800M -24.18466M -41.90708M -22.63927M
Net income applicable to common shares -42.54200M -14.85800M -24.18466M -41.90708M -22.63927M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 7.12M 47.22M 29.84M 3.38M 21.92M
Intangible assets 2.08M 1.92M 1.78M 1.60M 1.17M
Earning assets - - - - -
Other current assets - 3.08M 0.77M 0.48M 9.13M
Total liab 10.28M 11.93M 43.65M 15.06M 17.70M
Total stockholder equity -3.16400M 35.29M -13.80949M -11.68183M 4.22M
Deferred long term liab - - - - -
Other current liab 0.28M 10.55M 40.85M 15.03M 17.70M
Common stock 264.51M 263.36M 215.82M 194.86M 170.50M
Capital stock 264.51M 263.36M 215.82M 194.86M 170.50M
Retained earnings -284.68000M -253.88700M -239.02943M -214.84477M -172.93769M
Other liab - 0.06M - - -
Good will - - - - -
Other assets - - - - -
Cash 3.29M 32.31M 25.47M 0.81M 11.47M
Cash and equivalents - - 24.17M 0.67M -
Total current liabilities 8.96M 10.89M 42.90M 15.06M 17.70M
Current deferred revenue - - - - -
Net debt - -30.97900M -22.66675M -0.78542M -11.47124M
Short term debt 0.00000M 0.35M 2.05M 0.02M 0.00000M
Short long term debt - - 1.89M - -
Short long term debt total - 1.33M 2.80M 0.03M -
Other stockholder equity - 25.82M 9.40M 8.30M 7.17M
Property plant equipment 0.00000M 1.64M 1.11M 0.03M 0.00000M
Total current assets 5.04M 43.66M 26.95M 1.75M 20.74M
Long term investments - - - - -
Net tangible assets - 33.37M -15.58747M -13.28358M 3.04M
Short term investments - - - - 11.37M
Net receivables 0.00000M 8.28M 0.07M 0.08M 0.14M
Long term debt - - - - -
Inventory - - - - -
Accounts payable - 5.62M 4.08M 10.85M 6.45M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -0.14010M -0.00378M -0.51796M
Additional paid in capital - - - - -
Common stock total equity - - 215.82M 194.86M 170.50M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 1.63M 1.17M
Deferred long term asset charges - - - - -
Non current assets total 2.08M 3.56M 2.89M 1.63M 1.17M
Capital lease obligations 1.71M 1.33M 0.92M 0.03M -
Long term debt total 1.32M 0.98M 0.75M 0.00800M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.02000M -0.75500M -0.59937M -0.45804M -0.42059M
Change to liabilities - 1.09M -4.37137M 4.97M 4.23M
Total cashflows from investing activities -1.02000M -0.75500M -0.59937M -0.45804M -0.42059M
Net borrowings - 0.03M 1.41M -0.00510M -0.00510M
Total cash from financing activities -0.41900M 44.21M 26.10M 35.76M 27.16M
Change to operating activities - -1.59700M -0.00054M 0.00834M 0.00834M
Net income -42.54200M -14.85800M -24.18466M -41.90708M -22.63927M
Change in cash -29.01700M 6.84M 24.65M -10.65675M -14.65925M
Begin period cash flow 32.31M 25.47M 0.81M 11.47M 26.13M
End period cash flow 3.29M 32.31M 25.47M 0.81M 11.47M
Total cash from operating activities -27.57800M -36.61700M -0.84512M -45.96037M -41.39678M
Issuance of capital stock 0.00000M 34.18M 24.69M 35.77M 27.16M
Depreciation 0.86M 0.70M 0.24M 0.03M 0.03M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - -10.02800M -0.54443M 8.34M -6.50826M
Sale purchase of stock 0.00200M 12.71M 24.69M 35.77M 27.16M
Other cashflows from financing activities - 10.31M 1.50M -0.45804M -0.42059M
Change to netincome - -11.92100M 28.02M -17.38734M -16.50782M
Capital expenditures 1.02M 0.76M 0.60M 0.46M 0.42M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 12.19M -10.53700M -4.91580M 13.30M -2.27872M
Stock based compensation 4.08M 4.04M 1.10M 1.65M 1.51M
Other non cash items 0.13M -16.01300M 26.92M -19.03846M -18.01345M
Free cash flow -28.59800M -37.37200M -1.44449M -46.41840M -41.81736M

Fundamentals

  • Previous Close 0.06
  • Market Cap10.16M
  • Volume21085
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.33400M
  • Revenue TTM17.13M
  • Revenue Per Share TTM0.15
  • Gross Profit TTM 20.09M
  • Diluted EPS TTM-0.43

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TMD
Titan Medical Inc		 -0.005 8.33% 0.06 - - 0.59 2.03 0.54 -0.3059
QIPT
Quipt Home Medical Corp.		 -0.68 12.59% 4.72 - - - -
PRN
Profound Medical Corp		 0.07 0.61% 11.59 - - 40.82 5.05 35.48 -9.6771
HTL
Hamilton Thorne Ltd.		 0.02 1.45% 1.40 - - - -

Reports Covered

Stock Research & News

View All

Profile

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.

Titan Medical Inc

76 Berkeley Street, Toronto, ON, Canada, M5A 2W7

Key Executives

Name Title Year Born
Mr. Cary G. Vance CEO, Pres & Director 1966
Mr. Stephen L. Lemieux BA, CA, CPA, MMPA Chief Financial Officer NA
Mr. Jasminder Brar VP of Legal, IP & Strategic Initiatives, Corp. Sec. and Gen. Counsel NA
Ms. Kristen P. Galfetti VP of Investor Relations & Corp. Communications NA
Mr. Eric Heinz VP of Market & Corp. Devel. NA
Mr. Nate Jones Director of HR NA
Ms. Tammy Barnes Carrea VP of Quality and Regulatory Affairs NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).